Amniotic Fluid in Regenerative Medicine
Today, physicians are using regenerative cell therapies in the treatment of a wide variety of medical conditions and disorders. Presently, the use of amniotic fluid cells is commonly used in orthopedics as it may prevent many patients from having to resort to knee replacement or other surgical procedures and improve function of joints following injury or overuse. Practitioners today are also using regenerative cells in cases that involve pain management, cardiology, rheumatology and neurology to name a few.
Introduction to Anu RHEO+™
Anu RHEO+™ amniotic ﬂuid matrix products are aseptically prepared, minimally manipulated human tissue allografts for homologous use. Anu RHEO+™ is intended to supplement or replace damaged or inadequate connective tissue. Amniotic ﬂuid is the clear to slightly yellowish ﬂuid that surrounds a baby in the uterus. It acts as cushion against hard blows to protect the baby and also helps to regulate the temperature as well. Amniotic ﬂuid is a rich source of nutrients, cytokines, and growth factors that are required for fetal development and maturation.
The new RHEO+™ contains Wharton’s jelly; a mucous tissue within the umbilical cord that protects and insulates blood cells made from mucopolysaccharides such as hyaluronic acid and chondroitin sulfate. The MSC ‘s within Wharton’s jelly consist of functional myofibroblasts that can be isolated with minimal manipulation of the tissue, easily preserving their natural anti-inflammatory and pro-regenerative ability without complication or deterioration.
Anu RHEO+™ is a perfect match for synovial ﬂuid in joints and exhibits anti-scarring and anti-adhesion in addition to anti-inﬂammatory properties.
Types of Allografts we offer
Advantages of Anu RHEO+™ Over Corticosteroid Injections
Corticosteroid injections have been used for a very long time. Their anti-inﬂammatory and pain relief properties have made its use a common practice within the medical community. Corticosteroid injections have been shown to be eﬀective in decreasing the inﬂammation and pain of ligament injuries for up to 8 weeks. Simply, the body heals via inﬂammation, cortisone inhibits inﬂammation and healing by disrupting the three characteristic phases: inﬂammatory, proliferative and remodeling.
Amniotic ﬂuid has very similar characteristics to the synovial ﬂuid that is present in the joints. The natural lubrication and anti-inﬂammatory properties help to create an ideal environment for your body to help the proliferation and remodeling of the damaged tissue via the native regenerative cells present in the body.
Rheo Plus™ comes in 1cc and 2cc
Physicians Be Interested?
Anu RHEO+™ amniotic ﬂuid matrix products with Wharton’s Jelly provide the extracellular matrix needed for the inﬁltration, attachment and proliferation of cells required for the repair of damaged tissue. Amniotic ﬂuid may reduce scarring, ﬁbrosis, and adhesions in surgical and wound sites. It may also promote tissue regeneration by providing an anti-microbial and anti-inﬂammatory environment at surgical and wound sites.
The Clinical Benefits?
Typically used for minimally invasive treatment of damaged or inadequate tissue. Amniotic ﬂuid (AF) possesses anti-inﬂammatory, anti-microbial and regenerative properties that make it attractive for use in clinical applications.
Clinical Studies on the Capabilities of Amniotic Fluid
There are more than 200,000 peer reviewed scientific publications on pubmed and other medical journals with thousands discussing positive outcomes following the use of amniotic ﬂuid in regenerative medicine.
All birth tissue products are obtained from C-section deliveries from normal, full-term pregnancies. Donors that consent to use of their birth tissues are carefully screened prior to the use of their tissues in manufacturing.
Comprehensive medical and social histories of the donors are obtained and tissues are procured, processed, and tested to minimize potential risks of disease transmission to recipients. Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.
Each donor is tested for HBsAg (Hepatitis B Surface Antigen), HBcAb (hepatitis B core Antibody), HCV (hepatitis C Antibody), HIV I/II-Ab (Antibody to Human Immunodeﬁciency Virus Types 1 and Syphilis detection test, HIV NAT (HIV Nucleic Acid Test), and HCV NAT (HCV Nucleic Acid Test).
All products are tested post-sterilization to demonstrate the absence of bacterial and fungal pathogens and are non-pyrogenic. All testing results are reviewed by the Medical Director of Anu Life Sciences (15491 SW 12th Street, STE 408, Sunrise, FL 33326, 888-963-7881) prior to the release of the product.